StonvexLoading…
StonvexStonvexStonvexCore line items from CLW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.56B | $1.38B | $1.14B | $1.20B |
Operating Income | $-42.10M | $-64.50M | $78.10M | $99.30M |
Net Income | $-18.60M | $196.30M | $107.70M | $46.00M |
EPS (Diluted) | $-1.15 | $11.70 | $6.30 | $2.68 |
Total Assets | $1.59B | $1.68B | $1.67B | $1.70B |
Total Liabilities | $763.00M | $824.70M | $1.00B | $1.13B |
Cash & Equivalents | $30.70M | $79.60M | $42.00M | $53.70M |
Free Cash Flow OCF − CapEx | $-76.50M | $-55.20M | $117.00M | $116.70M |
Shares Outstanding | 16.17M | 16.78M | 17.09M | 17.18M |